Proteomic analysis identifies chaperone proteins as biomarkers in advanced cardiac involvement of AL amyloidosis, suggesting they may influence mortality risk.
Key Points
Mass spectrometry revealed essential roles for chaperone proteins in amyloid formation, particularly in patients with cardiac involvement.
The identification of biomarkers in cardiac-involved AL amyloidosis may enhance prognostic accuracy beyond Mayo staging.
Proteomic analysis across 76 patients illuminated distinct sequence characteristics of deposited clonal light chains.
Findings highlight the significance of cholesterol metabolism pathways, indicating potential therapeutic targets.